期刊文献+

Portal hypertension secondary to myelofibrosis with myeloid metaplasia:A study of 13 cases 被引量:10

Portal hypertension secondary to myelofibrosis with myeloid metaplasia:A study of 13 cases
暂未订购
导出
摘要 AIM:To describe the clinical presentation and complications of portal hypertension (PH) secondary to myelofibrosis with myeloid metaplasia (MMM).METHODS: Medical records for 123 patients with MMM were reviewed.RESULTS: Thirteen patients with PH secondary to MMM were identified. Median ages at time of MMM and PH diagnosis were 61 and 66 years, respectively. The interval from MMM diagnosis to presentation with one of the PH features ranged from 1 to 11 years. Variceal bleeding and ascites were the most common presentations. Of the eight patients who presented with variceal bleeding, six patients underwent endoscopic variceal ligation (EVL) with no variceal recurrence or hematological worsening during a 12-mo follow up period.CONCLUSION: Patients with MMM might develop PH. Exact mechanisms leading to PH in MMM are still controversial. As in other etiologies, variceal bleeding and ascites are the most common presentations. Anemia may correlate with, and/or predict, the severity of the PH presentation in these patients. EVL can successfully control variceal bleeding in MMM. Further clinical studies are required. AIM: To describe the clinical presentation and compli- cations of portal hypertension (PH) secondary to my- elofibrosis with myeloid metaplasia (MMM). METHODS: Medical records for 123 patients with MMM were reviewed. RESULTS: Thirteen patients with PH secondary to MMM were identified. Median ages at time of MMM and PH diagnosis were 61 and 66 years, respectively. The interval from MMM diagnosis to presentation with one of the PH features ranged from 1 to 11 years. Variceal bleeding and ascites were the most common presentations. Of the eight patients who presented with variceal bleeding, six patients underwent endoscopic variceal ligation (EVL) with no variceal recurrence or hematological worsening during a 12-mo follow up period. CONCLUSION: Patients with MMM might develop PH. Exact mechanisms leading to PH in MMM are still controversial. As in other etiologies, variceal bleeding and ascites are the most common presentations. Anemia may correlate with, and/or predict, the severity of the PH presentation in these patients. EVL can successfully control variceal bleeding in MMM. Further clinical studies are required.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第25期3128-3133,共6页 世界胃肠病学杂志(英文版)
关键词 Portal hypertension MYELOFIBROSIS Myeloid metaplasia ASCITES Variceal bleeding 骨髓 增生 继发 高压 纤维化 静脉曲张 临床表现 PH值
  • 相关文献

参考文献16

  • 1Rong Hua, Hui Cao and Zhi-Yong Wu Department of General Surgery, Renji Hospital, Shanghai 200127, China.Effects of hemoglobin concentration on hyperdynamic circulation associated with portal hypertension[J].Hepatobiliary & Pancreatic Diseases International,2006,5(2):215-218. 被引量:3
  • 2Brian K. P. Goh MBBS, MRCS, MMed,Juliana J. C. Chen MBBS, MRCS, MMed,Hiang-Khoon Tan MBBS, FRCS, PhD,Wei-Sean Yong MBBS, FRCS,Weng-Hoong Chan MBBS, FRCS.Acute Variceal Bleed in a Patient with Idiopathic Myelofibrosis Successfully Treated with Endoscopic Variceal Band Ligation[J].Digestive Diseases and Sciences.2007(1)
  • 3Wui-Chiang Lee,Han-Chieh Lin,Shyh-Haw Tsay,Ying-Ying Yang,Ming-Chih Hou,Fa-Yauh Lee,Full-Young Chang,Shou-Dong Lee.CASE REPORT: Esophageal Variceal Ligation for Esophageal Variceal Hemorrhage in a Patient with Portal and Primary Pulmonary Hypertension Complicating Myelofibrosis[J].Digestive Diseases and Sciences.2001(4)
  • 4Naoshi Tanaka M.D.,Koichiro Yamakado M.D.,Hisakazu Kihira M.D.,Akira Hashimoto M.D.,Takashi Murayama M.D.,Kan Takeda M.D.Letter to the Editor Re: Transjugular Intrahepatic Portosystemic Shunt for Intractable Esophageal-Gastric Variceal Hemorrhage in a Patient with Idiopathic Myelofibrosis[J].CardioVascular and Interventional Radiology.2000(6)
  • 5Isabel Cirera,Josep I. Elizalde,Josep M. Pique,Faust Feu,Maria Casadevall,Eran Goldin,Josep Teres,Jaume Bosch,Juan Rodes.Anemia Worsens Hyperdynamic Circulation of Patients with Cirrhosis and Portal Hypertension[J].Digestive Diseases and Sciences.1997(8)
  • 6Motohiro Takasaki,Isao Takahashi,Masahiro Takamatsu,Sejichi Yorimitsu,Yukio Yorimitsu,Isao Takeda,Tadashi Horimi.Endoscopic injection sclerotherapy for esophageal variceal hemorrhage in a patient with idiopathic myelofibrosis[J].Journal of Gastroenterology.1996(2)
  • 7Mesa RA,Barosi G,Cervantes F,Reilly JT,Tefferi A.Myelofibrosis with myeloid metaplasia:disease overview and non-transplant treatment options[].Bailliere s Best Practice and Research Clinical Haematology.2006
  • 8Escartín Marin P,Arenas Mirave JI,Boixeda D,Hernández Ranz F,García Plaza A.[Hemodynamic study of the portal system in6cases of myeloid metaplasia][].Revista Clinica Espanola.1977
  • 9Petz LD.Hematologic aspects of liver disease[].Current Opinion in Gastroenterology.1989
  • 10Pizcueta P,PiquéJM,Fernández M,Bosch J,Rodés J,Whittle BJ,Moncada S.Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition[].Gastroenterology.1992

二级参考文献3

共引文献2

同被引文献49

  • 1古丽巴哈尔.不典型原发性骨髓纤维化9例分析[J].中国误诊学杂志,2005,5(1):148-148. 被引量:4
  • 2陆林,肖志坚,陈辉树,林华,韩忠朝.56例45岁以下原发性骨髓纤维化患者的临床特点和预后分析[J].中华血液学杂志,2005,26(5):281-284. 被引量:4
  • 3Min Young Yun,Young Up Cho,In Suh Park,Sun Keun Choi,Sei Joong Kim,Seok Hwan Shin,Kyung Rae Kim.Eosinophilic gastroenteritis presenting as small bowel obstruction: A case report and review of the literature[J].World Journal of Gastroenterology,2007,13(11):1758-1760. 被引量:19
  • 4PJ Campbell,AR Green.Management of polycythemia vera and essential thrombocythemia. Hematol Am Soc Hematol Educ Program . 2005
  • 5Yoshida Hiroshi,Mamada Yasuhiro,Taniai Nobuhiko,Tajiri Takashi.New trends in surgical treatment for portal hypertension. Hepatology research : the official journal of the Japan Society of Hepatology . 2009
  • 6Shoelson SE,Lee J,Goldfine AB.Inflammation and insulin resistance[].Journal of Clinical Investigation The.2006
  • 7Katerina E. Panteli,Eleftheria C. Hatzimichael,Paraskevi K. Bouranta,Afroditi Katsaraki,Konstantinos Seferiadis,Justin Stebbing and Konstantinos L. Bourantas.Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases[].British Journal of Haematology.2005
  • 8Sikuler,E,Polio,J,Groszmann,RJ,Hendler,R.Glucagon and insulin metabolism in a portal hypertensive rat model[].American Journal of Physiology.1987
  • 9LeRoith D,Fonseca V,Vinik A.Metabolic memory in diabetes - focus on insulin[].Diabetes Metabolism Reviews.2005
  • 10N Lanati,E Emanuele,N Brondino,D Geroldi.Soluble RAGE-modulating drugs: state-of-the-art and future perspectives for targeting vascular inflammation[].Curr Vasc Pharmacol.2010

引证文献10

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部